NASDAQ
CNS Pharmaceuticals, Inc. (CNSP) has a free cash flow growth of -51.62% as of Friday, May 29, 2026. This represents a 3387.25% decrease compared to its 12-month average of -1.48%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.